ADARx Pharmaceuticals submitted a Form 4 filing for 29 September 2026, which was published on Reuters’ Stock Market feed on 30 September 2026 at 07:36 am. The article contains only the filing header and does not disclose any insider transaction details, share quantities, prices, or parties involved. No comments or additional information were provided in the release.